跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SANTYL - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
SANTYL
Authorized
STANDARD
SANTYL
Smith & Nephew Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
8a8fefe34d5b77b3
Company
Smith & Nephew Inc
Type
Standard
Approval Details
Approval Id
8a8fefe34d5b77b3
Drug Approval Canada Name
SANTYL
Product Name
SANTYL
Status
Dormant
Status Date
2024-02-22
Original Market Date
1994-12-31
Din
02063670
Drug Class
Human
Dosage Form
Ointment
Route Of Administration
Topical
Schedule
Prescription , Schedule D
Ahfs
84:92.00
Atc Original
D03BA02 COLLAGENASE
Atc Name
d 03 ba 02
Aig Number
0112254001
Company Name
Smith & Nephew Inc
Company Address
1919 Minnesota Court, Suite 403, Mississauga, Ontario, Canada, L5N 0C9
Company Detail Path
/organization/smith-and-nephew-inc-canada
Company Information
Pharmaceutical Company Name
Smith & Nephew Inc
Country Name
Canada
Province Name
Ontario
City Name
mississauga,ontario,country_ca
Address
2280 Argentia Rd
Active Ingredients
COLLAGENASE
250 UNIT / G
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
8a8fefe34d5b77b3
Type
Standard
Back to Health Canada Approvals